Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stoke Therapeutics (STOK) Receivables - Net (2024 - 2025)

Historic Receivables - Net for Stoke Therapeutics (STOK) over the last 2 years, with Q3 2025 value amounting to $9.2 million.

  • Stoke Therapeutics' Receivables - Net changed N/A to $9.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.2 million, marking a year-over-year change of. This contributed to the annual value of $1.7 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Stoke Therapeutics reported Receivables - Net of $9.2 million as of Q3 2025.
  • Over the past 5 years, Stoke Therapeutics' Receivables - Net peaked at $9.2 million during Q3 2025, and registered a low of $1.7 million during Q4 2024.